# LAMOTRIGINE
> **ANDA213949** · Abbreviated New Drug Application (Generic) · Sponsor: YILING · Approved 2021-12-08
## Drug
- **FDA Application Number:** ANDA213949
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMOTRIGINE
- **Generic name:** LAMOTRIGINE EXTENDED-RELEASE
- **Active ingredients:** LAMOTRIGINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** YILING
- **Manufacturer:** Yiling Pharmaceutical, Inc.
- **First approval:** 2021-12-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213949)
---
*AI Analytics · CC0 1.0*